Multiple myeloma

Multiple myeloma (MM) is a malignant tumor of plasma cell characterized by overproduction of abnormal plasma cells in the bone marrow and skeletal destruction. The clinical features are bone pain, renal impairment, immunodeficiency, anemia and presence of abnormal immunoglobulins (Ig).

Dysfibrinogenemia

Qualitatively abnormal fibrinogen.


Total: 3

                       


(per page)
PMID (PMCID)
22842111
 FEMALE
A case of acquired dysfibrinogenemia in multiple myeloma treated with therapeutic plasma exchange.
Post GR, James L, Alapat D, Guillory V, Cottler-Fox M, Nakagawa M.
Transfus Apher Sci. 2013;48(1):35-8.
A case of acquired dysfibrinogenemia in multiple myeloma treated with therapeutic plasma exchange.
18841003
 MALE
Acquired dysfibrinogenemia secondary to multiple myeloma.
Kotlin R, Sobotkova A, Riedel T, Salaj P, Suttnar J, Reicheltova Z, Majek P, Khaznadar T, Dyr JE.
Acta Haematol. 2008;120(2):75-81.
Acquired dysfibrinogenemia associated with multiple myeloma was diagnosed in the 72-year-old patient.
18841003
 MALE
Acquired dysfibrinogenemia secondary to multiple myeloma.
Kotlin R, Sobotkova A, Riedel T, Salaj P, Suttnar J, Reicheltova Z, Majek P, Khaznadar T, Dyr JE.
Acta Haematol. 2008;120(2):75-81.
Acquired dysfibrinogenemia secondary to multiple myeloma.